Virtu Financial’s Neos Therapeutics, Inc NEOS Stock Holding History

Virtu Financial’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-41,401	Closed	-$26K	–	2337
2020 Q4	$26K	Buy	41,401 +17,204	+71%	+$10.6K	﹤0.01%	1336
2020 Q3	$13K	Buy	+24,197	New	+$16.4K	﹤0.01%	947
2019 Q4	$42K	Buy	+27,813	New	+$41.7K	﹤0.01%	1226
2019 Q3	–	Sell	-19,705	Closed	-$25K	–	2001
2019 Q2	$25K	Sell	19,705 -30,717	-61%	-$56.5K	﹤0.01%	1323
2019 Q1	$131K	Buy	+50,422	New	+$118K	0.01%	1087
2018 Q2	–	Sell	-21,779	Closed	-$181K	–	2688
2018 Q1	$181K	Sell	21,779 -4,480	-17%	-$42.8K	0.01%	1400
2017 Q4	$268K	Buy	+26,259	New	+$252K	0.01%	1368

Virtu Financial's NEOS Position: Q1 2021 in Review

Virtu Financial sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 41,401 shares — an estimated $26K sold.

Virtu Financial first reported a position in NEOS in Q4 2017 and held it in 7 quarters. The position peaked at $268K in Q4 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.

Virtu Financial reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
Virtu Financial sold 41,401 Neos Therapeutics, Inc shares in Q1 2021, an estimated $26K.
Virtu Financial first reported a position in Neos Therapeutics, Inc in Q4 2017 and held it in 7 quarters.
Virtu Financial's Neos Therapeutics, Inc position peaked at $268K in Q4 2017.
0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.

Based on Virtu Financial's 13F filing for Q1 2021, filed 19 May 2021.